CN115677790A - Method for synthesizing paeoniflorin derivative - Google Patents

Method for synthesizing paeoniflorin derivative Download PDF

Info

Publication number
CN115677790A
CN115677790A CN202110839768.8A CN202110839768A CN115677790A CN 115677790 A CN115677790 A CN 115677790A CN 202110839768 A CN202110839768 A CN 202110839768A CN 115677790 A CN115677790 A CN 115677790A
Authority
CN
China
Prior art keywords
paeoniflorin
synthesizing
reaction
content
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110839768.8A
Other languages
Chinese (zh)
Inventor
唐顺之
许文东
袁诚
傅玉萍
彭万才
白柏
李松涛
李继荣
魏劭恒
陈文�
李佳俐
李遥
毛禹康
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Hanfang Pharmaceutical Co ltd
Original Assignee
Guangzhou Hanfang Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Hanfang Pharmaceutical Co ltd filed Critical Guangzhou Hanfang Pharmaceutical Co ltd
Priority to CN202110839768.8A priority Critical patent/CN115677790A/en
Priority to PCT/CN2021/124537 priority patent/WO2023000518A1/en
Publication of CN115677790A publication Critical patent/CN115677790A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms

Abstract

The invention provides a synthesis method of a paeoniflorin derivative shown in formula III, which can obviously reduce the consumption of a reaction solvent, shorten the reaction time, has the characteristics of economy, saving, simple operation, mild conditions and greatly improved reaction yield, is suitable for carrying out wider structural modification on paeoniflorin, and can meet the requirement of industrialization.

Description

Method for synthesizing paeoniflorin derivative
Technical Field
The invention belongs to the technical field of chemical synthesis, and particularly relates to a synthesis method of a paeoniflorin derivative.
Background
Paeoniflorin, a major component of Total Glucosides of Paeony (TGP), has been used in the clinical treatment of rheumatoid arthritis. However, TGP has some disadvantages such as slow onset of action, large individual difference in therapeutic effect, low bioavailability, etc. It has also been found in clinical practice that some patients experience gastrointestinal reactions such as diarrhea and loss of appetite when the oral dosage is increased. Therefore, the paeoniflorin is structurally modified to improve the curative effect and the bioavailability, and is more beneficial to the recovery of patients.
Therefore, the prior art provides an esterification method using 4-Dimethylaminopyridine (DMAP) as a catalyst, and although the paeoniflorin-6-O' -benzene sulfonate compound with better curative effect is synthesized by the method, the method has the defects of large organic solvent dosage, addition of pyridine with certain reproductive toxicity and acylating reagent acyl chloride in a slow dropwise manner, low yield and the like, and is not beneficial to environmental protection and industrial production. Therefore, an efficient and economic paeoniflorin esterification method is developed, and convenience is brought to the search of a paeoniflorin derivative with a better curative effect and subsequent industrial production.
Disclosure of Invention
The present invention has been made to solve at least one of the above-mentioned problems occurring in the prior art. Therefore, the invention provides a synthesis method of paeoniflorin derivatives, which can obviously reduce the dosage of reaction solvents, shorten the reaction time and greatly improve the reaction yield and content.
Specifically, the invention provides a synthesis method of a paeoniflorin derivative shown in a formula III, which comprises the following reaction route:
Figure BDA0003178423650000011
specifically, the synthesis method comprises the following steps: dissolving paeoniflorin or a crude product of paeoniflorin in an organic solvent, adding a metal catalyst for catalysis, and carrying out esterification reaction under the action of an acid-binding agent and acyl chloride R-Cl to obtain the paeoniflorin derivative.
Wherein R-Cl is selected from C 1 ~C 20 Substituted and unsubstituted acyl chloride and C 1 ~C 20 Substituted and unsubstituted sulfonyl chlorides.
In some embodiments of the invention, R is selected from:
Figure BDA0003178423650000021
in some embodiments of the present invention, the crude paeoniflorin is derived from a natural plant extract, such as at least one extract from radix Paeoniae alba, radix Paeoniae Rubra, cortex moutan, dog head, peony root, and purple peony, wherein the paeoniflorin content is greater than 40%.
In the invention, the paeoniflorin is catalyzed by adopting a metal catalyst
Figure BDA0003178423650000022
The esterification reaction can obviously improve the reaction efficiency and the product yield; the acyl chloride can be added at one time without dropwise addition, in order to realize paeoniflorin derivative
Figure BDA0003178423650000023
The synthesis of (a) provides a convenient industrial production scheme.
In some preferred embodiments of the present invention, the crude paeoniflorin is obtained by two-step column chromatography of natural plant extract on alumina and silica gel, and the paeoniflorin content is greater than 40%; preferably, the paeoniflorin content in the natural plant extract is more than 50%; more preferably, the paeoniflorin content in the natural plant extract is more than 60%; most preferably, the paeoniflorin content in the natural plant extract is greater than 70%.
In some preferred embodiments of the present invention, the molar ratio of paeoniflorin or crude paeoniflorin to the acid chloride is 1: (0.5-2); preferably 1: (0.8-2).
Compared with the existing synthesis process, the dosage of acyl chloride is reduced due to the efficient selective synthesis of the catalyst, and the slow dropwise addition within at least 3 hours in the prior art is changed into the one-time addition in the acyl chloride feeding mode, so that the industrial production is facilitated.
In some more preferred embodiments of the invention, the metal catalyst is selected from C 1 ~C 4 Alkyl tin halides, aryl tin halides, C 1 ~C 4 Alkyl tin oxide of (2) 1 ~C 4 Or a combination thereof; further preferably, the metal catalyst is selected from dimethyltin dichloride, diethyltin dichloride, dibutyltin dichloride, dimethyltin sulfide, dimethyltin oxide, or a combination thereof.
In some more preferred embodiments of the present invention, the molar ratio of paeoniflorin or crude paeoniflorin to the metal catalyst is 1: (0.001-1.5); preferably 1: (0.01-0.2); more preferably 1: (0.01-0.1).
In some more preferred embodiments of the present invention, the acid scavenger is at least one selected from the group consisting of triethylamine, N' -diisopropylethylamine, pyridine, potassium carbonate, potassium bicarbonate, sodium carbonate, and sodium bicarbonate.
In some more preferred embodiments of the present invention, the molar ratio of the paeoniflorin or crude paeoniflorin to the acid-binding agent is 1: (1-2); preferably 1: (1.2-1.6).
In some more preferred embodiments of the present invention, the mass-to-volume ratio of the paeoniflorin or the crude paeoniflorin to the organic solvent is 1: (2-10) g/mL; preferably 1: (4-8) g/mL; more preferably 1: (5-7) g/mL. Compared with the prior art in which the dosage of the organic solvent is 20-80 times of the weight of the paeoniflorin, the volume of the organic solvent is only 2-10 times of the weight of the paeoniflorin, and the dosage of the reaction organic solvent is obviously reduced.
In some more preferred embodiments of the present invention, the organic solvent is selected from at least one of tetrahydrofuran, acetone, methyl ethyl ketone, N' -dimethylformamide, acetonitrile, 1, 4-dioxane, dimethylsulfoxide.
In some more preferred embodiments of the present invention, the temperature of the esterification reaction is from-40 ℃ to 70 ℃; more preferably 20 to 30 ℃.
In some more preferred embodiments of the present invention, the time for the esterification reaction is 0.5h to 10.0h; preferably 1.0h to 4.0h.
In some more preferred embodiments of the present invention, after said esterification, a purification step is further included; further preferably, the purification is carried out in an extraction and concentration mode; still more preferably, the specific operations of the purification are: adding an extracting agent into the esterification product for extraction, and concentrating an organic layer to obtain the paeoniflorin-6-O' -benzene sulfonate.
In some more preferred embodiments of the invention, the extractant is ethyl acetate and water.
In some more preferred embodiments of the present invention, the mass to volume ratio of paeoniflorin or crude paeoniflorin to the ethyl acetate is 1: (5-15) g/mL; preferably 1: (8-13) g/mL.
In some more preferred embodiments of the present invention, the mass-to-volume ratio of paeoniflorin or crude paeoniflorin to the water is 1: (2.5-10) g/mL; preferably 1: (3-8) g/mL; more preferably 1: (4-7) g/mL.
The invention has the beneficial effects that:
the synthesis method disclosed by the invention has the characteristics of less catalyst and organic solvent consumption, short reaction time, no need of dropwise adding raw materials and the like, namely has the characteristics of economy, simplicity in operation and mild conditions, can greatly improve the reaction yield, is suitable for carrying out wider paeoniflorin structural modification, and can meet the industrial requirement.
Drawings
The invention is further described with reference to the following figures and examples, in which:
FIG. 1 is a mass spectrum of the product of example 1 of the present invention.
FIG. 2 is a hydrogen spectrum of the product of example 1 of the present invention.
FIG. 3 is a carbon spectrum of the product of example 1 of the present invention.
FIG. 4 is a liquid chromatogram of example 1 and comparative example 1 of the present invention.
FIG. 5 is a liquid chromatogram of comparative example 2 and comparative example 3 of the present invention.
Detailed Description
The concept and technical effects of the present invention will be clearly and completely described below in conjunction with the embodiments to fully understand the objects, features and effects of the present invention. It is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments, and other embodiments obtained by those skilled in the art without inventive efforts are within the protection scope of the present invention based on the embodiments of the present invention.
Example 1
The paeoniflorin-6-O' -benzene sulfonate is prepared by the following specific steps:
dissolving 6g of pure paeoniflorin (the content is 98%) in 25mL of acetone at room temperature, adding 0.04g of dibutyltin dichloride for activation for 10min after complete dissolution, then sequentially adding 3.3mL of N, N' -Diisopropylethylamine (DIPEA) and 1.6mL of benzenesulfonyl chloride for reaction for 2h, detecting by TLC (a developing agent ratio is: chloroform: absolute ethanol = 8) for reaction, extracting with 60mL of ethyl acetate and 30mL of water after complete reaction, separating liquid, and concentrating until dry to obtain 7.6g of white solid, wherein the yield is 98.2% and the content is 93.1% according to molar weight. The mass spectrum, hydrogen spectrum and carbon spectrum of the product are respectively shown in figure 1, figure 2 and figure 3. The results of the liquid phase assay are shown in FIG. 4.
Example 2
The paeoniflorin-6-O' -p-methylbenzenesulfonate is prepared by the following specific steps:
adding dry ice into ethylene glycol to prepare a cooling bath at about-10 ℃, dissolving 6g of paeoniflorin (with the content of 98%) in 25mL of acetone, then placing the solution in the cooling bath, adding 0.06g of dibutyltin dichloride for activation for 10min after the paeoniflorin is completely dissolved, then sequentially adding 3.3mL of N, N' -Diisopropylethylamine (DIPEA) and 2.4g of p-toluenesulfonyl chloride for reaction for 3h, carrying out TLC detection reaction, extracting and separating the solution by using 70mL of ethyl acetate and 35mL of water after the reaction is completely finished, concentrating the solution until the solution is dried to obtain 7.6g of white solid, wherein the yield is 95.8% according to molar weight and the content is 90%.
Example 3
In this example, paeoniflorin-6-O' -2-fluorobenzenesulfonate was prepared by the following steps:
dissolving 10g of paeoniflorin (the content is 98%) in 30mL of N, N' -Dimethylformamide (DMF) at room temperature, adding 0.10g of dimethyltin dichloride to activate for 10min after complete dissolution, sequentially adding 4.3g of potassium carbonate and 4.1g of 2-fluorobenzenesulfonyl chloride to react for 3.5h, detecting by TLC, extracting and separating by using 100mL of ethyl acetate and 70mL of water after complete reaction, and concentrating to dryness to obtain 11.2g of white solid, wherein the yield is 84.1% and the content is 91%.
Example 4
The paeoniflorin-6-O' -4-chlorobenzenesulfonate prepared by the embodiment comprises the following specific processes:
dissolving 10g of paeoniflorin (with the content of 98%) in 50mL of acetonitrile at room temperature, adding 0.10g of dimethyltin dichloride to activate for 10min after complete dissolution, sequentially adding 3.5mL of triethylamine and 4.1g of 4-fluorobenzenesulfonyl chloride to react for 1h, detecting by TLC, extracting and separating by using 90mL of ethyl acetate and 50mL of water after complete reaction, and concentrating to dryness to obtain 11.8g of white solid with the yield of 87.1% and the content of 91%.
Example 5
The paeoniflorin-6-O' -3-methoxybenzenesulfonate is prepared by the following specific steps:
dissolving 10g of paeoniflorin (the content is 98%) in 50mL of Tetrahydrofuran (THF) at room temperature, adding 4g of dimethyltin dichloride to activate for 10min after complete dissolution, sequentially adding 3.5mL of triethylamine and 2.95mL of 3-methoxybenzenesulfonyl chloride to react for 0.5h, detecting by TLC (thin layer chromatography), extracting and separating by using 90mL of ethyl acetate and 50mL of water after complete reaction, and concentrating to dryness to obtain 13g of white solid, wherein the yield is 96.3% and the content is 95.6%.
Example 6
In this example, paeoniflorin-6-O' -4-iodobenzene sulfonate was prepared by the following steps:
dissolving 10g of paeoniflorin (the content is 98%) in 40mL of acetone under the condition of water bath at 40 ℃, adding 0.2g of diethyl tin dichloride for activation for 10min after complete dissolution, sequentially adding 3.5mL of triethylamine and 9.4g of 4-iodobenzene sulfonyl chloride for reaction for 5h, detecting by TLC (thin layer chromatography), extracting and separating by using 100mL of ethyl acetate and 50mL of water after complete reaction, and concentrating to dryness to obtain 14.5g of white solid with the yield of 93.3% and the content of 90%.
Example 7
The paeoniflorin-6-O' -3-phenylpropionate is prepared by the following specific steps:
dissolving 6g of paeoniflorin (with the content of 98%) in 30mL of acetone at the temperature of 0 ℃, adding 0.07g of dimethyl tin sulfide for activation for 10min after complete dissolution, sequentially adding 3mL of triethylamine and 1.9mL of 3-phenylpropionyl chloride for reaction for 5h, detecting by TLC (thin layer chromatography), extracting and separating liquid by using 60mL of ethyl acetate and 30mL of water after complete reaction, and concentrating to be dry to obtain 12.6g of white solid with the yield of 98.8% and the content of 93%.
Example 8
The paeoniflorin-6-O' -benzene sulfonate is prepared by the following specific steps:
dissolving 10g of paeoniflorin (the content is 98%) in 40mL of acetone under the condition of water bath at 25 ℃, adding 0.07g of dimethyl tin oxide to activate for 10min after complete dissolution, sequentially adding 4.3mL of triethylamine and 2.7mL of benzenesulfonyl chloride to react for 5h, detecting by TLC, extracting and separating by using 100mL of ethyl acetate and 50mL of water after complete reaction, and concentrating until the mixture is dried to obtain 11g of white solid with the yield of 85.1% and the content of 80%.
Example 9
The paeoniflorin-6-O' -benzene sulfonate is prepared by the following specific steps:
dissolving 10g of paeoniflorin (the content is 98%) in 60mL of acetonitrile under the condition of 65 ℃ water bath, adding 0.08g of dimethyl tin oxide to activate for 10min after complete dissolution, sequentially adding 4.3mL of triethylamine and 2.7mL of benzene sulfonyl chloride to react for 1h, detecting by TLC, extracting and separating by using 100mL of ethyl acetate and 50mL of water after complete reaction, and concentrating until the mixture is dried to obtain 11.7g of white solid, wherein the yield is 90.6% and the content is 85%.
Example 10
The paeoniflorin-6-O' -benzene sulfonate is prepared by the following specific steps:
dissolving 10g of paeoniflorin extract (the content is 44.7%) in 60mL of acetonitrile at room temperature, adding 0.04g of dimethyl tin oxide to activate for 10min after complete dissolution, sequentially adding 2.3mL of triethylamine and 1.7mL of benzenesulfonyl chloride to react for 6h, detecting by TLC, extracting and separating by using 100mL of ethyl acetate and 50mL of water after complete reaction, and concentrating to dry to obtain 4.4g of white solid with the yield of 76.2% and the content of 36%.
Example 11
The paeoniflorin-6-O' -benzene sulfonate is prepared by the following specific steps:
dissolving 10g of crude paeoniflorin (with the content of 66.3%) in 60mL of acetonitrile at room temperature, adding 0.07g of dimethyl tin oxide to activate for 10min after complete dissolution, sequentially adding 4mL of triethylamine and 2mL of benzene sulfonyl chloride to react for 10h, detecting by TLC, extracting and separating by using 110mL of ethyl acetate and 60mL of water after complete reaction, and concentrating to dry to obtain 6g of white solid with the yield of 79.5% and the content of 57%.
Example 12
In this example, a crude paeoniflorin product is prepared, and the specific process is as follows:
collecting 50g of paeoniflorin extract (paeoniflorin content is 44.7%), adding 100mL of isopropanol, dissolving, adding 150g of neutral alumina, stirring, adsorbing, adding adsorbed neutral alumina into a chromatographic column, eluting with 200mL of isopropanol, collecting eluate, and concentrating to obtain 28.4g of paeoniflorin intermediate with paeoniflorin content of 78.3%. The obtained paeoniflorin intermediate was dissolved using 100mL of a solvent (chloroform: ethanol = 5) and 450g of silica gel was packed, and the eluent was chloroform: ethanol =9:1, eluting by silica gel column chromatography, eluting by 2.75L in total, collecting eluent, and concentrating under reduced pressure to obtain 23.7g of crude paeoniflorin with the content of 90.5%.
Example 13
The paeoniflorin-6-O' -benzene sulfonate is prepared by the following specific steps:
under the condition of room temperature, 100kg (the content is 90%) of crude paeoniflorin is stirred and dissolved completely in a reaction concentration tank by using 312kg of acetone, 1kg of dimethyltin dichloride is added into the reaction tank to be activated for 15min, 27.6kg of triethylamine and 36.7kg of benzenesulfonyl chloride are sequentially added to react for 2h, TLC detection reaction is carried out in the reaction process, after the reaction is completed, 1000kg of ethyl acetate and 500kg of water are added into the reaction concentration tank to be stirred and extracted for 5min, standing is carried out for 1h for liquid separation, an organic layer is reserved and concentrated to be dry, and the solid content is measured at the same time: 300mL of the organic layer solution was concentrated to dryness to give 23.3g, and the organic layer concentration was about 0.078g/mL (0.078 kg/L), and the volume of the organic layer solution after conversion to acetone and ethyl acetate was 1506L, whereby the organic layer contained about 117.5kg of the product as a white solid in a yield of 91.1% and a content of 82%.
Comparative example 1
The paeoniflorin-6-O' -benzene sulfonate is prepared according to the optimal conditions in the prior art by the specific process:
6g of paeoniflorin (content: 98%) is dissolved in a mixed solution of 36mL of chloroform and 8mL of pyridine at room temperature, and then 50mg of 4-dimethylaminopyridine is added for activation for 30min. Dissolving 3.2mL of benzene sulfonyl chloride in 4mL of dichloromethane within 3h, then dripping into the reaction solution for reaction, continuing the reaction for 6.5h after the dripping is finished, and detecting the reaction by TLC in the reaction process. After the reaction, after concentrating to an oily substance, 60mL of ethyl acetate was added and extracted three times, 60mL of 1M hydrochloric acid was added each time, and the remaining organic layer was concentrated to 6.1g of a yellow oily viscous substance with a yield of 78.8% and a content of 80.1%. The results of the liquid phase assay are shown in FIG. 4.
Comparative example 2
The comparative example prepares paeoniflorin-6-O' -benzene sulfonate, and the specific process is as follows:
dissolving 6g of crude paeoniflorin (the content is 90.5%) in 25mL of acetone at room temperature, adding 0.04g of dibutyltin dichloride for activation for 10min after complete dissolution, sequentially adding 3.3mL of N, N' -Diisopropylethylamine (DIPEA) and 1.6mL of benzenesulfonyl chloride for reaction for 2h, detecting by TLC, extracting with 60mL of ethyl acetate and 30mL of water after complete reaction, separating liquid, and concentrating until the mixture is dried to obtain 7.5g of white solid, wherein the yield is 91.1% and the content is 89.6%. The liquid phase detection results are shown in FIG. 5.
Comparative example 3
The comparative example prepares paeoniflorin-6-O' -benzene sulfonate, and the specific process is as follows:
6g of crude paeoniflorin (90.5% in content) is dissolved in a mixed solution of 36mL of chloroform and 8mL of pyridine at room temperature, and then 50mg of 4-dimethylaminopyridine is added for activation for 30min. Dissolving 3.2mL of benzene sulfonyl chloride in 4mL of dichloromethane within 3h, then dripping into the reaction solution for reaction, continuing to react for 6.5h after dripping is finished, and detecting the reaction by TLC in the reaction process. After the reaction, after concentrating to an oily substance, 60mL of ethyl acetate was added and extracted three times, 60mL of 1M hydrochloric acid was added each time, and the remaining organic layer was concentrated to 5.4g of a yellow oily viscous substance with a yield of 69.8% and a content of 73.9%. The liquid phase detection results are shown in FIG. 5.
Table 1 summary of the results of example 1 and comparative examples
Figure BDA0003178423650000081
Compared with the comparative examples 1-3, and the combination of fig. 4 and fig. 5, the content and yield of the technology of the invention are better than those of the prior art after the pure paeoniflorin is reacted by different reaction methods: specifically, the content of the pure paeoniflorin is 93.1% after the reaction by the technical method of the invention, the yield is 98.2%, wherein 12 impurity peaks with impurity content of more than 0.05% are provided, 10 impurity peaks with impurity content of more than 0.1% are provided, and 80.1% impurity peak with impurity content of more than 0.05% and 78.8% yield are provided after the reaction by the prior art, 21 impurity peaks with impurity content of more than 0.05% are provided, and 18 impurity peaks with impurity content of more than 0.1% are provided. In the self-made paeoniflorin, the technical method is also better than the prior art; the invention has better tolerance to the reaction raw materials, and the reaction product has the characteristics of high content and less impurities, thereby being beneficial to industrial production and reducing the production cost.
In addition, in examples 1 to 9, the catalyst activation time and the addition time of the intermediate materials such as acyl chloride, acid binding agent and the like are obviously shorter than those of comparative example 1, the reaction solvent required by comparative example 1 is about 2 times of that required by example 1, and a second solvent pyridine with certain reproductive toxicity and high boiling point is also used in the reaction process of comparative example 1; in addition, in the aspect of adding acyl chloride, the mode of adding acyl chloride at one time is adopted in examples 1-9, while the mode of dropwise adding slowly is adopted in comparative example 1, the time is required to be 3 hours, so that the whole reaction time is longer. In addition, the invention adopts organic metal catalyst, can raise the reaction efficiency apparently, shorten reaction time; whereas example 1 is improved by 10% or more in reaction yield compared to comparative example 1. Therefore, the technical scheme of the invention obviously reduces the using amount of the reaction solvent, reduces the production cost, has short production process time, is environment-friendly and high in safety, and greatly improves the reaction yield.
The embodiments of the present invention have been described in detail, but the present invention is not limited to the embodiments, and various changes can be made without departing from the gist of the present invention within the knowledge of those skilled in the art. Furthermore, the embodiments of the present invention and the features of the embodiments may be combined with each other without conflict.

Claims (10)

1. A method for synthesizing a paeoniflorin derivative of formula III, which is characterized in that: the method comprises the following steps: dissolving paeoniflorin or a crude product of paeoniflorin in an organic solvent, adding a metal catalyst for catalysis, and carrying out esterification reaction under the action of an acid-binding agent and acyl chloride R-Cl to obtain a paeoniflorin derivative;
Figure FDA0003178423640000011
wherein the crude paeoniflorin is derived from natural plant extract, wherein the content of paeoniflorin is more than 40%;
the R-Cl is selected from C 1 ~C 20 Substituted and unsubstituted acyl chlorides; preferably C 1 ~C 20 Substituted and unsubstituted sulfonyl chlorides.
2. The method for synthesizing paeoniflorin derivative according to claim 1, wherein: based on paeoniflorin, the molar ratio of the paeoniflorin or the crude paeoniflorin to the acyl chloride is 1: (0.5-2).
3. The method for synthesizing paeoniflorin derivatives according to claim 1, wherein: the metal catalyst is selected from C 1 ~C 4 Alkyl tin halides, aryl tin halides, C 1 ~C 4 Alkyl tin oxide of (2) 1 ~C 4 Or a combination thereof.
4. The method for synthesizing paeoniflorin derivatives according to claim 1 or 3, wherein: based on paeoniflorin, the molar ratio of the paeoniflorin or the crude paeoniflorin to the metal catalyst is 1: (0.001-1.5).
5. The method for synthesizing paeoniflorin derivative according to claim 1, wherein: the acid-binding agent is selected from triethylamine, N' -diisopropylethylamine, pyridine, potassium carbonate, potassium bicarbonate, sodium carbonate, sodium bicarbonate or a combination thereof.
6. The method for synthesizing paeoniflorin derivative according to claim 1, wherein: the organic solvent is selected from tetrahydrofuran, acetone, methyl ethyl ketone, N' -dimethylformamide, acetonitrile, 1, 4-dioxane, dimethyl sulfoxide or a combination thereof.
7. The method for synthesizing paeoniflorin derivatives according to claim 1 or 6, wherein: the mass volume ratio of the paeoniflorin to the organic solvent is 1: (1-20) g/mL.
8. The method for synthesizing paeoniflorin derivative according to claim 1, wherein: the temperature of the esterification reaction is-40 ℃ to 70 ℃.
9. The method for synthesizing paeoniflorin derivatives according to claim 1 or 8, wherein: the esterification reaction time is 0.5 h-10.0 h.
10. The method for synthesizing paeoniflorin derivative according to claim 1, wherein: after the esterification reaction, a purification step is also included.
CN202110839768.8A 2021-07-23 2021-07-23 Method for synthesizing paeoniflorin derivative Pending CN115677790A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202110839768.8A CN115677790A (en) 2021-07-23 2021-07-23 Method for synthesizing paeoniflorin derivative
PCT/CN2021/124537 WO2023000518A1 (en) 2021-07-23 2021-10-19 Method for synthesizing paeoniflorin derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110839768.8A CN115677790A (en) 2021-07-23 2021-07-23 Method for synthesizing paeoniflorin derivative

Publications (1)

Publication Number Publication Date
CN115677790A true CN115677790A (en) 2023-02-03

Family

ID=84980465

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110839768.8A Pending CN115677790A (en) 2021-07-23 2021-07-23 Method for synthesizing paeoniflorin derivative

Country Status (2)

Country Link
CN (1) CN115677790A (en)
WO (1) WO2023000518A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102643316B (en) * 2011-11-28 2017-06-13 宁波立华制药有限公司 A kind of acylated glycosides compound and its preparation method and application
CN102603827B (en) * 2012-02-10 2014-10-29 魏伟 Paeoniflorin aromatic ester derivative, preparation method and applications thereof
CN104098617A (en) * 2013-04-08 2014-10-15 南京工业大学 Preparation method of sucrose-6-acetate
CN109481452A (en) * 2019-01-07 2019-03-19 安徽医科大学 A kind of purposes of Paeoniflorin -6-O '-benzene sulfonate

Also Published As

Publication number Publication date
WO2023000518A1 (en) 2023-01-26

Similar Documents

Publication Publication Date Title
CN104250232A (en) Preparation method of parecoxib sodium
CN112125805B (en) Water-soluble magnolol derivative, preparation method of honokiol derivative and intermediate thereof, and related monohydroxy protected intermediate
CN116284189B (en) Method for synthesizing MANT-GTPγS
EP4159728A1 (en) Preparation method for cdk4/6 inhibitor
AU2016365535B2 (en) Method for producing N-retinoylcysteic acid alkyl ester
CN106543220A (en) Phosphoramidate compounds and preparation method thereof and crystal
CN106749259A (en) A kind of synthetic method of cyclopenta pyrimido azoles
CN106905254B (en) A kind of preparation method of 5- phenyl -1H- tetrazole
CN115677790A (en) Method for synthesizing paeoniflorin derivative
CN102532228B (en) The preparation of 2 '-O-(2-methoxyethyl) adenosine and 2 '-O-(2-methoxyethyl) guanosine and derivative thereof and purification process thereof
CN104513241B (en) New regadenoson intermediate, preparation method and application thereof
CN104926900B (en) A kind of method of capecitabine intermediate shown in preparation formula I
CN110317129A (en) The synthetic method of the bromo- 5- metoxyphenol of 2-
CN106831927B (en) A kind of synthetic method of Astragaloside IV
WO2023000636A1 (en) Method for synthesis of (3-fluorooxetan-3-yl)methyl 4-methylbenzenesulfonate
CN111793047B (en) Preparation method of eribulin intermediate
CN107216361B (en) The preparation method of rope Citropten
CN112441998B (en) Preparation method of eribulin intermediate
CN105884846B (en) A kind of synthetic method of 2'-deoxyadenosine
CN105503976B (en) A kind of rope Citropten intermediate
CN103664837A (en) Preparation method of high-purity cabazitaxel intermediate
CN114591347B (en) Moxidectin intermediate and preparation method thereof, and preparation method of moxidectin
CN114478407B (en) Preparation method and application of chiral homopiperazine and derivatives thereof
CN113845410B (en) Synthesis method of magnolol derivative and intermediate thereof
CN114539288B (en) Preparation method of everolimus

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination